Oral vitamin D supplementation has a lower bioavailability and reduces hypersecretion of parathyroid hormone and insulin resistance in obese Chinese males
Authors:
- 17 December 2014
- journal article
- research article
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 18 (12) , 2211-2219
Abstract
Objective: To examine the vitamin D status, SNP of the vitamin D receptor gene (VDR) and the effects of vitamin D supplementation on parathyroid hormone and insulin secretion in adult males with obesity or normal weight in a subtropical Chinese city.Design: An intervention trial.Setting: Shenzhen City, Guangdong Province, China.Subjects: From a cross-sectional survey conducted from June to July, eighty-two normal-weight and ninety-nine obese males (18–69 years) were screened to analyse their vitamin D status and for five SNP of VDR. From these individuals, in the same season of a different year, obese and normal-weight male volunteers (twenty-one per group) were included for an intervention trial with oral vitamin D supplementation at 1250 µg/week for 8 weeks.Results: For the survey, there was no significant difference (P>0·05) in baseline circulating 25-hydroxyvitamin D concentrations or in the percentages of participants in different categories of vitamin D status between the two groups. The VDR SNP, rs3782905, was significantly associated with obesity (P=0·043), but none of the examined SNP were correlated with serum 25-hydroxyvitamin D when adjusted for age, BMI and study group. After vitamin D supplementation, serum 25-hydroxyvitamin D concentration, hypersecretions of parathyroid hormone and insulin, and insulin resistance in the obese were changed beneficially (P<0·05); however, the increase in serum 25-hydroxyvitamin D was less than that of the normal-weight men.Conclusions: For obese and normal-weight men of subtropical China, the summer baseline vitamin D status was similar. However, oral vitamin D supplementation revealed a decreased bioavailability of vitamin D in obese men and ameliorated their hypersecretion of parathyroid hormone and insulin resistance.Keywords
This publication has 64 references indexed in Scilit:
- The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanismsNutrition Journal, 2013
- Vitamin D and ObesityNutrients, 2013
- Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993–2009Obesity Reviews, 2011
- 25‐Hydroxyvitamin D Concentration Correlates With Insulin‐Sensitivity and BMI in ObesityObesity, 2010
- A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolutionGenome Research, 2010
- Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose HomeostasisInternational Journal of Endocrinology, 2010
- Vitamin D Status: Measurement, Interpretation, and Clinical ApplicationAnnals of Epidemiology, 2009
- Vitamin D3 in fat tissueEndocrine, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium IntakeJAMA, 2005